Toward global prevention of sexually transmitted infections (STIs): The need for STI vaccines.

An estimated 499 million curable sexually transmitted infections (STIs; gonorrhea, chlamydia, syphilis, and trichomoniasis) occurred globally in 2008. In addition, well over 500 million people are estimated to have a viral STI such as herpes simplex virus type 2 (HSV-2) or human papillomavirus (HPV) at any point in time. STIs result in a large global burden of sexual, reproductive, and maternal-child health consequences, including genital symptoms, pregnancy complications, cancer, infertility, and enhanced HIV transmission, as well as important psychosocial consequences and financial costs. STI control strategies based primarily on behavioral primary prevention and STI case management have had clear successes, but gains have not been universal. Current STI control is hampered or threatened by several behavioral, biological, and implementation challenges, including a large proportion of asymptomatic infections, lack of feasible diagnostic tests globally, antimicrobial resistance, repeat infections, and barriers to intervention access, availability, and scale-up. Vaccines against HPV and hepatitis B virus offer a new paradigm for STI control. Challenges to existing STI prevention efforts provide important reasons for working toward additional STI vaccines. We summarize the global epidemiology of STIs and STI-associated complications, examine challenges to existing STI prevention efforts, and discuss the need for new STI vaccines for future prevention efforts.

The role of substance abuse treatment in preventing human immunodeficiency virus transmission among injecting drug users

This exploratory study assesses the utility of substance abuse treatment as a strategy for preventing human immunodeficiency virus (HIV) transmission among injecting drug users (IDUs). Data analyzed in this study were collected in San Antonio, TX, 1989 through 1995 using both qualitative and quantitative methods. Qualitative data included ethnographic interviews with 234 active IDUs; quantitative data included baseline risk assessments and HIV screening plus interviews follow-up interviews administered approximately six months later to 823 IDUs participating in a Federally-funded AIDS community outreach demonstration project.^ Findings that have particularly important implications for substance abuse treatment as an HIV prevention strategy for IDUs are listed below. (1) IDUs who wanted treatment were significantly more likely to be daily heroin users. (2) IDUs who want treatment were significantly more likely to have been to treatment previously. (3) IDUs who wanted treatment at baseline reported significantly higher levels of HIV risk than IDUs who did not want treatment. (4) IDUs who went to treatment between their baseline and follow-up interviews reported significantly higher levels of HIV risk at baseline than IDUs who did not go to treatment. (5) IDUs who went to treatment between their baseline and follow-up interviews reported significantly greater decreases in injection-related HIV risk behaviors. (6) IDUs who went to treatment reported significantly greater decreases in sexual HIV risk behaviors than IDUs who did not go to treatment.^ This study also noted a number of factors that may limit the effectiveness of substance abuse treatment in reducing HIV risk among IDUs. Findings suggest that the impact of methadone maintenance on HIV risk behaviors among opioid dependent IDUs may be limited by the negative manner in which it is perceived by IDUs as well as other elements of society. One consequence of the negative perception of methadone maintenance held by many elements of society may be an unwillingness to provide public funding for an adequate number of methadone maintenance slots. Thus many IDUs who would be willing to enter methadone maintenance are unable to enter it and many IDUs who do enter it are forced to drop out prematurely. ^

Serosurveillance of Schmallenberg virus in Switzerland using bulk tank milk samples.

Infections with Schmallenberg virus (SBV), a novel Orthobunyavirus transmitted by biting midges, can cause abortions and malformations of newborns and severe symptoms in adults of domestic and wild ruminants. Understanding the temporal and spatial distribution of the virus in a certain territory is important for the control and prevention of the disease. In this study, seroprevalence of antibodies against SBV and the spatial spread of the virus was investigated in Swiss dairy cattle applying a milk serology technique on bulk milk samples. The seroprevalence in cattle herds was significantly higher in December 2012 (99.5%) compared to July 2012 (19.7%). This high between-herd seroprevalence in cattle herds was observed shortly after the first detection of viral infections. Milk samples originating from farms with seropositive animals taken in December 2012 (n=209; mean 160%) revealed significantly higher S/P% ratios than samples collected in July 2012 (n=48; mean 103.6%). This finding suggests a high within-herd seroprevalence in infected herds which makes testing of bulk tank milk samples for the identification farms with past exposures to SBV a sensitive method. It suggests also that within-herd transmission followed by seroconversion still occurred between July and December. In July 2012, positive bulk tank milk samples were mainly restricted to the western part of Switzerland whereas in December 2012, all samples except one were positive. A spatial analysis revealed a separation of regions with and without positive farms in July 2012 and no spatial clustering within the regions with positive farms. In contrast to the spatial dispersion of bluetongue virus, a virus that is also transmitted by Culicoides midges, in 2008 in Switzerland, the spread of SBV occurred from the western to the eastern part of the country. The dispersed incursion of SBV took place in the western part of Switzerland and the virus spread rapidly to the remaining territory. This spatial pattern is consistent with the hypothesis that transmission by Culicoides midges was the main way of spreading.

The epidemiology of Hepatitis B and Hepatitis C virus infection among college students who are not US/Canadian born in Houston

Introduction. A vast majority of studies conducted in both developed and developing nations have focused on the epidemiology of HBV (Hepatitis B virus) and HCV (Hepatitis C virus) in high-risk populations; low-risk populations have been neglected. Recently Hwang et al conducted a unique large cross-sectional study in American university students that focused on cosmetic procedures and drug use for acquiring these infections among a low-risk young adult population In Houston. ^ Methods. This study is a secondary data analysis of the cross-sectional study conducted by Hwang et al. Data for this anonymous study were collected from 7,960 college students, among whom were the 2,561 non US/Canadian born students included in this study. All students completed a self-administered questionnaire and provided a blood sample. The epidemiology of HBV/HCV and risk factors for acquiring HBV/HCV infection was studied by comparing those with HBV/HCV infection versus those without. Both univariate and multivariate logistic regression was used to analyze the data. ^ Results. Overall prevalence of HBV and HCV infections were 22% and 0.8% respectively. By multivariable analysis, the factors that were independently associated with increased prevalence of HBV infection were increasing age per year (OR=1.06, 95% C.I=1.04-1.08), Black or Asian race (OR=6.21, 95% C.I=3.14-12.27), history of household contact with hepatitis (OR=1.87, 95% C.I=1.15-3.05), and having sexual partner with hepatitis (OR=5.20, 95% C.I=1.5-18.00). For HCV these factors included increasing age per year (OR= 1.08, 95% C.I=1.03-1.14), history of blood transfusion prior to 1991 (OR=25.45, 95% C.I=7.58-85.40), and Injection drug use. (OR=78.15, 95% C.I=12.19-500.85). Cosmetic procedures like tattooing were not significant risk factors for either HBV or HCV infection. ^ Conclusions. In a low-risk adult foreign born population, cosmetic procedures are not significant risk factors for HBV or HCV infection. The prevention strategies of these infections in this population should focus on safe sexual practices/abstinence and HBV vaccination should be provided to adolescents and sexually active adults. ^

Hepatitis C and human immunodeficiency virus infections in injecting drug users in drug treatment centers in Vietnam

Background. Injecting drug users (IDUs) are at risk of infection with Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV). Independently, each of these viruses is a serious threat to health, with HIV ravaging the body’s immune system, and HCV causing cirrhosis, liver cancer and liver failure. Co-infection with HIV/HCV weakens the response to antiretroviral therapy in HIV patients. IDUs with HIV/HCV co-infection are at a 20 times higher risk of having liver-related morbidity and mortality than IDUs with HIV alone. In Vietnam, studies to ascertain the prevalence of HIV have found high rates, but little is known about their HCV status. ^ Purpose. To measure the prevalence of HCV and HIV infection and identify factors associated with these viruses among IDUs at drug treatment centers in northern Vietnam. ^ Methods. A cross-sectional study was conducted from November 2007 to February 2008 with 455 injecting drug users aged 18 to 39 years, admitted no more than two months earlier to one of four treatment centers in Northern Vietnam (Hatay Province) (response rate=95%). Participants, all of whom had completed detoxification and provided informed consent, completed a risk assessment questionnaire and had their blood drawn to test for the presence of antibody-HCV and antibody-HIV with enzyme immuno assays. Univariate and multivariable logistic regression models were utilized to explore the strength of association using HIV, HCV infections and HIV/HCV co-infection as outcomes and demographic characteristics, drug use and sexual behaviors as factors associated with these outcomes. Unadjusted and adjusted odds ratios and 95% confidence intervals were calculated. ^ Results. Among all IDU study participants, the prevalence of HCV alone was 76.9%, HIV alone was 19.8%. The prevalence of HIV/HCV co-infection was 92.2% of HIV-positive and 23.7% of HCV-positive respondents. No sexual risk behaviors for lifetime, six months or 30 days prior to admission were significantly associated with HCV or HIV infection among these IDUs. Only duration of injection drug use was independently associated with HCV and HIV infection, respectively. Longer duration was associated with higher prevalence. Nevertheless, while HCV infection among IDUs who reported being in their first year of injecting drugs were lower than longer time injectors, their rates were still substantial, 67.5%. ^ Compared with either HCV mono-infection or HIV/HCV non-infection, HIV/HCV co-infection was associated with the length of drug injection history but was not associated with sexual behaviors. Higher education was associated with a lower prevalence of HIV/HCV co-infection. When compared with HIV/HCV non-infection, current marriage was associated with a lower prevalence of HIV/HCV co-infection. ^ Conclusions. HCV was prevalent among IDUs from 18 to 39 years old at four drug treatment centers in northern Vietnam. Co-infection with HCV was predominant among HIV-positive IDUs. HCV and HIV co-infection were closely associated with the length of injection drug history. Further research regarding HCV/HIV co-infection should include non-injecting drug users to assess the magnitude of sexual risk behaviors on HIV and HCV infection. (At these treatment centers non-IDUs constituted 10-20% of the population.) High prevalence of HCV prevalence among IDUs, especially among HIV-infected IDUs, suggests that drug treatment centers serving IDUs should include not only HIV prevention education but they should also include the prevention of viral hepatitis. In addition, IDUs who are HIV-positive need to be tested for HCV to receive the best course of therapy and achieve the best response to HIV treatment. These data also suggest that because many IDUs get infected with HCV in the first year of their injection drug career, and because they also engaged in high risk sexual behaviors, outreach programs should focus on harm reduction, safer drug use and sexual practices to prevent infection among drug users who have not yet begun injecting drugs and to prevent further spread of HCV, HIV and co-infection. ^

Spatial analysis of water body distance and West Nile Virus human cases in Houston, TX

West Nile Virus (WNV) is an arboviral disease that has affected hundreds of residents in Harris County, Texas since its introduction in 2002. Persistent infection, lingering sequelae and other long-term symptoms of patients reaffirm the need for prevention of this important vector-borne disease. This study aimed to determine if living within 400m of a water body increases one’s odds of infection with WNV. Additionally, we wanted to determine if one’s proximity to a particular water type or water body source increased one’s odds of infection with WNV.^ 145 cases’ addresses were abstracted from the initial interview and consent records from a cohort of patients (Epidemiology of Arboviral Encephalitis in Houston study, HSC-SPH-03-039). After applying inclusion criteria, 140 cases were identified for analysis. 140 controls were selected for analysis using a population proportionate to size model and US Census Bureau data. MapMarker USA v14 was used to geocode the cases’ addresses. Both cases’ and controls’ coordinates were uploaded onto a Harris County water shapefile in MapInfo Professional v9.5.1. Distance in meters to the closest water source, closest water source type, and closest water source name were recorded.^ Analysis of Variance (p=0.329, R2 = 0.0034) indicated no association between water body distance and risk of WNV disease. Living near a creek (x2 = 11.79, p < 0.001), or the combined group of creek and gully (x 2 = 14.02, p < 0.001) were found to be strongly associated with infection of WNV. Living near Cypress Creek and its feeders (x2 = 15.2, p < 0.001) was found to be strongly associated with WNV infection. We found that creek and gully habitats, particularly Cypress Creek, were preferential for the local disease transmitting Culex quinquefasciatus and reservoir avian population.^

Seasonality of respiratory syncytial virus infection in Texas

Respiratory syncytial virus (RSV) is a common cause of respiratory infection in infants and children that can result in bronchiolitis or pneumonia. Each year in the United States, it causes up to 400 deaths and 125,000 hospitalizations among children less than one year of age. RSV is transmitted by direct or close contact with contaminated secretions, which may involve droplets and fomites. Monthly administration of a monoclonal RSV antibody, palivizumab (Synagis™, MedImmune, Gaithersburg, MD), in premature infants, infants with chronic lung disease, or congenital heart disease has been shown to significantly reduce the risk of severe RSV infection. The Centers for Disease Control and Prevention's (CDC) National Respiratory and Enteric Virus Surveillance System (NREVSS) is a laboratory based passive reporting system that collects state, regional, and national RSV data. The CDC defines the RSV season onset as “the first of 2 consecutive weeks during which the mean percentage of specimens testing positive for RSV antigen is 10%.” RSV season offset is defined as the last of 2 consecutive weeks during which the percentage of positive specimens is less than or equal to 10%. Annual RSV epidemics generally occur during the winter and early spring months, but the RSV season is known to vary by national regions. Precise delineation of the RSV epidemiology by region could maximize protection from RSV and minimize the cost of RSV immune prophylaxis. ^ The purpose of this thesis is to define the RSV season in Texas over time; compare the RSV season of the state of Texas and its regions with the national norms; and to compare RSV seasonality between the various regions in Texas. ^ This study was a retrospective analysis of data reported to NREVSS to evaluate potential disparities in the onset weeks, offset weeks, and duration of the annual RSV season in Texas. Data were collected from 70 reporting sites, and includes information from the 2004–2005 to 2009–2010 RSV seasons. ^ The observed median onset (week 44) and offset week (week 8) for the Texas were consistent with national estimates for the South. Regional estimates and statistical analysis suggested that the RSV season in Texas would be better represented by regions. Regional seasonal comparisons revealed considerable variation in season offset and duration between many of the geographic regions within Texas. This trend should be studied further.^

Correlation of tuberculosis and human immunodeficiency virus in Harris County, Texas from 2009 through 2010 using Geographic Information Systems

A population based ecological study was conducted to identify areas with a high number of TB and HIV new diagnoses in Harris County, Texas from 2009 through 2010 by applying Geographic Information Systems to determine whether distinguished spatial patterns exist at the census tract level through the use of exploratory mapping. As of 2010, Texas has the fourth highest occurrence of new diagnoses of HIV/AIDS and TB.[31] The Texas Department of State Health Services (DSHS) has identified HIV infected persons as a high risk population for TB in Harris County.[29] In order to explore this relationship further, GIS was utilized to identify spatial trends. ^ The specific aims were to map TB and HIV new diagnoses rates and spatially identify hotspots and high value clusters at the census tract level. The potential association between HIV and TB was analyzed using spatial autocorrelation and linear regression analysis. The spatial statistics used were ArcGIS 9.3 Hotspot Analysis and Cluster and Outlier Analysis. Spatial autocorrelation was determined through Global Moran's I and linear regression analysis. ^ Hotspots and clusters of TB and HIV are located within the same spatial areas of Harris County. The areas with high value clusters and hotspots for each infection are located within the central downtown area of the city of Houston. There is an additional hotspot area of TB located directly north of I-10 and a hotspot area of HIV northeast of Interstate 610. ^ The Moran's I Index of 0.17 (Z score = 3.6 standard deviations, p-value = 0.01) suggests that TB is statistically clustered with a less than 1% chance that this pattern is due to random chance. However, there were a high number of features with no neighbors which may invalidate the statistical properties of the test. Linear regression analysis indicated that HIV new diagnoses rates (β=−0.006, SE=0.147, p=0.970) and census tracts (β=0.000, SE=0.000, p=0.866) were not significant predictors of TB new diagnoses rates. ^ Mapping products indicate that census tracts with overlapping hotspots and high value clusters of TB and HIV should be a targeted focus for prevention efforts, most particularly within central Harris County. While the statistical association was not confirmed, evidence suggests that there is a relationship between HIV and TB within this two year period.^

Compromisos en la adaptación a distintos huéspedes en virus de plantas

Los patógenos han desarrollado estrategias para sobrevivir en su entorno, infectar a sus huéspedes, multiplicarse dentro de estos y posteriormente transmitirse a otros huéspedes. Todos estos componentes hacen parte de la eficacia biológica de los patógenos, y les permiten ser los causantes de enfermedades infecciosas tanto en hombres y animales, como en plantas. El proceso de infección produce efectos negativos en la eficacia biológica del huésped y la gravedad de los efectos, dependerá de la virulencia del patógeno. Por su parte, el huésped ha desarrollado mecanismos de respuesta en contra del patógeno, tales como la resistencia, por la que reduce la multiplicación del patógeno, o la tolerancia, por la que disminuye el efecto negativo de la infección. Estas respuestas del huésped a la infección producen efectos negativos en la eficacia biológica del patógeno, actuando como una presión selectiva sobre su población. Si la presión selectiva sobre el patógeno varía según el huésped, se predice que un mismo patógeno no podrá aumentar su eficacia biológica en distintos huéspedes y estará más adaptado a un huésped y menos a otro, disminuyendo su gama de huéspedes. Esto supone que la adaptación de un patógeno a distintos huéspedes estará a menudo dificultada por compromisos (trade-off) en diferentes componentes de la eficacia biológica del patógeno. Hasta el momento, la evidencia de compromisos de la adaptación del patógeno a distintos huéspedes no es muy abundante, en lo que se respecta a los virus de plantas. En las últimas décadas, se ha descrito un aumento en la incidencia de virus nuevos o previamente descritos que producen enfermedades infecciosas con mayor gravedad y/o diferente patogenicidad, como la infección de huéspedes previamente resistentes. Esto se conoce como la emergencia de enfermedades infecciosas y está causada por patógenos emergentes, que proceden de un huésped reservorio donde se encuentran adaptados. Los huéspedes que actúan como reservorios pueden ser plantas silvestres, que a menudo presentan pocos síntomas o muy leves a pesar de estar infectados con diferentes virus, y asimismo se encuentran en ecosistemas con ninguna o poca intervención humana. El estudio de los factores ecológicos y biológicos que actúan en el proceso de la emergencia de enfermedades infecciosas, ayudará a entender sus causas para crear estrategias de prevención y control. Los virus son los principales patógenos causales de la emergencia de enfermedades infecciosas en humanos, animales y plantas y un buen modelo para entender los procesos de la emergencia. Asimismo, las plantas a diferencia de los animales, son huéspedes fáciles de manipular y los virus que las afectan, más seguros para el trabajo en laboratorio que los virus de humanos y animales, otros modelos también usados en la investigación. Por lo tanto, la interacción virus – planta es un buen modelo experimental para el estudio de la emergencia de enfermedades infecciosas. El estudio de la emergencia de virus en plantas tiene también un interés particular, debido a que los virus pueden ocasionar pérdidas económicas en los cultivos agrícolas y poner en riesgo la durabilidad de la resistencia de plantas mejoradas, lo que supone un riesgo en la seguridad alimentaria con impactos importantes en la sociedad, comparables con las enfermedades infecciosas de humanos y animales domésticos. Para que un virus se convierta en un patógeno emergente debe primero saltar desde su huésped reservorio a un nuevo huésped, segundo adaptarse al nuevo huésped hasta que la infección dentro de la población de éste se vuelva independiente del reservorio y finalmente debe cambiar su epidemiología. En este estudio, se escogió la emergencia del virus del mosaico del pepino dulce (PepMV) en el tomate, como modelo experimental para estudiar la emergencia de un virus en una nueva especie de huésped, así como las infecciones de distintos genotipos del virus del moteado atenuado del pimiento (PMMoV) en pimiento, para estudiar la emergencia de un virus que aumenta su patogenicidad en un huésped previamente resistente. El estudio de ambos patosistemas nos permitió ampliar el conocimiento sobre los factores ecológicos y evolutivos en las dos primeras fases de la emergencia de enfermedades virales en plantas. El PepMV es un patógeno emergente en cultivos de tomate (Solanum lycopersicum) a nivel mundial, que se describió primero en 1980 infectando pepino dulce (Solanum muricatum L.) en Perú, y casi una década después causando una epidemia en cultivos de tomate en Holanda. La introducción a Europa posiblemente fue a través de semillas infectadas de tomate procedentes de Perú, y desde entonces se han descrito nuevos aislados que se agrupan en cuatro cepas (EU, LP, CH2, US1) que infectan a tomate. Sin embargo, el proceso de su emergencia desde pepino dulce hasta tomate es un interrogante de gran interés, porque es uno de los virus emergentes más recientes y de gran importancia económica. Para la emergencia de PepMV en tomate, se recolectaron muestras de tomate silvestre procedentes del sur de Perú, se analizó la presencia y diversidad de aislados de PepMV y se caracterizaron tanto biológicamente (gama de huéspedes), como genéticamente (secuencias genomicas). Se han descrito en diferentes regiones del mundo aislados de PMMoV que han adquirido la capacidad de infectar variedades previamente resistentes de pimiento (Capsicum spp), es decir, un típico caso de emergencia de virus que implica la ampliación de su gama de huéspedes y un aumento de patogenicidad. Esto tiene gran interés, ya que compromete el uso de variedades resistentes obtenidas por mejora genética, que es la forma de control de virus más eficaz que existe. Para estudiar la emergencia de genotipos altamente patogénicos de PMMoV, se analizaron clones biológicos de PMMoV procedentes de aislados de campo cuya patogenicidad era conocida (P1,2) y por mutagénesis se les aumentó la patogenicidad (P1,2,3 y P1,2,3,4), introduciendo las mutaciones descritas como responsables de estos fenotipos. Se analizó si el aumento de la patogenicidad conlleva un compromiso en la eficacia biológica de los genotipos de PMMoV. Para ello se evaluaron diferentes componentes de la eficacia biológica del virus en diferentes huéspedes con distintos alelos de resistencia. Los resultados de esta tesis demuestran: i). El potencial de las plantas silvestres como reservorios de virus emergentes, en este caso tomates silvestres del sur de Perú, así como la existencia en estas plantas de aislados de PepMV de una nueva cepa no descrita que llamamos PES. ii) El aumento de la gama de huéspedes no es una condición estricta para la emergencia de los virus de plantas. iii) La adaptación es el mecanismo más probable en la emergencia de PepMV en tomate cultivado. iv) El aumento de la patogenicidad tiene un efecto pleiotrópico en distintos componentes de la eficacia biológica, así mismo el signo y magnitud de este efecto dependerá del genotipo del virus, del huésped y de la interacción de estos factores. ABSTRACT host Pathogens have evolved strategies to survive in their environment, infecting their hosts, multiplying inside them and being transmitted to other hosts. All of these components form part of the pathogen fitness, and allow them to be the cause of infectious diseases in humans, animals, and plants. The infection process produces negative effects on the host fitness and the effects severity will depend on the pathogen virulence. On the other hand, hosts have developed response mechanisms against pathogens such as resistance, which reduces the growth of pathogens, or tolerance, which decreases the negative effects of infection. T he se responses of s to infection cause negative effects on the pathogen fitness, acting as a selective pressure on its population. If the selective pressures on pathogens va ry according to the host s , probably one pathogen cannot increase its fitness in different hosts and will be more adapted to one host and less to another, decreasing its host range. This means that the adaptation of one pathogen to different hosts , will be often limited by different trade - off components of biological effectiveness of pathogen. Nowadays , trade - off evidence of pathogen adaptation to different hosts is not extensive, in relation with plant viruses. In last decades, an increase in the incidence of new or previously detected viruses has been described, causing infectious diseases with increased severity and/or different pathogenicity, such as the hosts infection previously resistants. This is known as the emergence of infectious diseases and is caused by emerging pathogens that come from a reservoir host where they are adapted. The hosts which act as reservoirs can be wild plants, that often have few symptoms or very mild , despite of being infected with different viruses, and being found in ecosystems with little or any human intervention. The study of ecological and biological factors , acting in the process of the infectious diseases emergence will help to understand its causes to create strategies for its prevention and control. Viruses are the main causative pathogens of the infectious diseases emergence in humans, animals and plants, and a good model to understand the emergency processes. Likewise, plants in contrast to animals are easy host to handle and viruses that affect them, safer for laboratory work than viruses of humans and animals, another models used in research. Therefore, the interaction plant-virus is a good experimental model for the study of the infectious diseases emergence. The study of virus emergence in plants also has a particular interest, because the viruses can cause economic losses in agricultural crops and threaten the resistance durability of improved plants, it suppose a risk for food security with significant impacts on society, comparable with infectious diseases of humans and domestic animals. To become an emerging pathogen, a virus must jump first from its reservoir host to a new host, then adapt to a new host until the infection within the population becomes independent from the reservoir, and finally must change its epidemiology. In this study, the emergence of pepino mosaic virus (PepMV) in tomato, was selected as experimental model to study the emergence of a virus in a new host specie, as well as the infections of different genotypes of pepper mild mottle virus (PMMoV) in pepper, to study the emergence of a virus that increases its pathogenicity in a previously resistant host. The study of both Pathosystems increased our knowledge about the ecological and evolutionary factors in the two first phases of the emergence of viral diseases in plants. The PepMV is an emerging pathogen in tomato (Solanum lycopersicum L.) in the world, which was first described in 1980 by infecting pepino (Solanum muricatum L.) in Peru, and almost after a decade caused an epidemic in tomato crops in Netherlands. The introduction to Europe was possibly through infected tomato seeds from Peru, and from then have been described new isolates that are grouped in four strains (EU, LP, CH2, US1) that infect tomato. However, the process of its emergence from pepino up tomato is a very interesting question, because it is one of the newest emerging viruses and economically important. For the PepMV emergence in tomato, wild tomato samples from southern Peru were collected, and the presence and diversity of PepMV isolates were analyzed and characterized at biological (host range) and genetics (genomic sequences) levels. Isolates from PMMoV have been described in different world regions which have acquired the ability to infect pepper varieties that were previously resistants (Capsicum spp), it means, a typical case of virus emergence which involves the host range extension and an increased pathogenicity. This is of great interest due to involve the use of resistant varieties obtained by breeding, which is the most effective way to control virus. To study the emergence of highly pathogenic genotypes of PMMoV, biological clones from field isolates whose pathogenicity was known were analyzed (P1,2) and by mutagenesis we increased its pathogenicity (P1,2,3 and P1,2, 3,4), introducing the mutations described as responsible for these phenotypes. We analyzed whether the increased pathogenicity involves a trade-off in fitness of PMMoV genotypes. For this aim, different components of virus fitness in different hosts with several resistance alleles were evaluated. The results of this thesis show: i). The potential of wild plants as reservoirs of emerging viruses, in this case wild tomatoes in southern Peru, and the existence in these plants of PepMV isolates of a new undescribed strain that we call PES. ii) The host range expansion is not a strict condition for the plant virus emergence. iii) The adaptation is the most likely mechanism in the PepMV emergence in cultivated tomato. iv) The increased pathogenicity has a pleiotropic effect on several fitness components, besides the sign and magnitude of this effect depends on the virus genotype, the host and the interaction of both.

Long-term correction of obesity and diabetes in genetically obese mice by a single intramuscular injection of recombinant adeno-associated virus encoding mouse leptin

The ob/ob mouse is genetically deficient in leptin and exhibits a phenotype that includes obesity and non-insulin-dependent diabetes melitus. This phenotype closely resembles the morbid obesity seen in humans. In this study, we demonstrate that a single intramuscular injection of a recombinant adeno-associated virus (AAV) vector encoding mouse leptin (rAAV-leptin) in ob/ob mice leads to prevention of obesity and diabetes. The treated animals show normalization of metabolic abnormalities including hyperglycemia, insulin resistance, impaired glucose tolerance, and lethargy. The effects of a single injection have lasted through the 6-month course of the study. At all time points measured the circulating levels of leptin in the serum were similar to age-matched control C57 mice. These results demonstrate that maintenance of normal levels of leptin (2–5 ng/ml) in the circulation can prevent both the onset of obesity and associated non-insulin-dependent diabetes. Thus a single injection of a rAAV vector expressing a therapeutic gene can lead to complete and long-term correction of a genetic disorder. Our study demonstrates the long-term correction of a disease caused by a genetic defect and proves the feasibility of using rAAV-based vectors for the treatment of chronic disorders like obesity.

SPC3, a synthetic peptide derived from the V3 domain of human immunodeficiency virus type 1 (HIV-1) gp120, inhibits HIV-1 entry into CD4+ and CD4- cells by two distinct mechanisms.

The third variable region (V3 loop) of gp120, the HIV-1 surface envelope glycoprotein, plays a key role in HIV-1 infection and pathogenesis. Recently, we reported that a synthetic multibranched peptide (SPC3) containing eight V3-loop consensus motifs (GPGRAF) inhibited HIV-1 infection in both CD4+ and CD4- susceptible cells. In the present study, we investigated the mechanisms of action of SPC3 in these cell types--i.e., CD4+ lymphocytes and CD4- epithelial cells expressing galactosylceramide (GalCer), an alternative receptor for HIV-1 gp120. We found that SPC3 was a potent inhibitor of HIV-1 infection in CD4+ lymphocytes when added 1 h after initial exposure of the cells to HIV-1, whereas it had no inhibitory effect when present only before and/or during the incubation with HIV-1. These data suggested that SPC3 did not inhibit the binding of HIV-1 to CD4+ lymphocytes but interfered with a post-binding step necessary for virus entry. In agreement with this hypothesis, SPC3 treatment after HIV-1 exposure dramatically reduced the number of infected cells without altering gp120-CD4 interaction or viral gene expression. In contrast, SPC3 blocked HIV-1 entry into CD4-/GalCer+ human colon epithelial cells when present in competition with HIV-1 but had no effect when added after infection. Accordingly, SPC3 was found to inhibit the binding of gp120 to the GalCer receptor. Thus, the data suggest that SPC3 affects HIV-1 infection by two distinct mechanisms: (i) prevention of GalCer-mediated HIV-1 attachment to the surface of CD4-/GalCer+ cells and (ii) post-binding inhibition of HIV-1 entry into CD4+ lymphocytes.

The virus cancer program:

Mode of access: Internet.

The 2014 chikungunya virus outbreak in the U.S. Virgin Islands: epidemiology, long-term health outcomes, and economic burden

Thesis (Ph.D.)--University of Washington, 2016-06

Prevention of Cervical Cancer Through Papillomavirus Vaccination

A subset of human papillomaviruses (HPVs) promote anogenital malignancy, including cervical cancer, and prevention and treatment strategies that reflect the causal role of HPV are being developed. Vaccines based on HPV virus-like particles induce genotype-specific virus-neutralizing antibody and prevent infection with HPV1. Persistent papillomavirus infection is required for the development of papillomavirus-associated cancer and, therefore, therapeutic vaccines are being developed to eliminate established papillomavirus infection. Such vaccines test principles for the growing field of tumour-antigen-specific immunotherapy. This article reviews progress in the field and draws conclusions for the development of future prophylactic and therapeutic viral vaccines.